1 terminated, 1 unknown. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 1, Unknown 1 |
Follow ARDS, Human: new trials by email Literature Review of ARDS, Human trials Research Report on ARDS, Human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of BZ371B in ARDS Patients Inhaled BZ371B - ARDS, ARDS, Human | Early Phase 1 | Terminated | Biozeus Biopharmaceutical S.A. | 1 | 2022-11-23 | 2023-06-01 |
| Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords - ARDS, Human, Covid-19 | Early Phase 1 | Unknown | Instituto de Medicina Regenerativa | 9 | 2020-04-16 | 2024-03-06 |
Respiratory Distress Syndrome (2) · COVID-19 (1) · Lung Diseases (1)
Respiration Disorders (2) · Respiratory Tract Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Biozeus Biopharmaceutical S.A. (1) · Instituto de Medicina Regenerativa (1)
Brazil (1) · Mexico (1)
Jesus Perez (1) · Juan Parcero (1) · Marcelo BP Amato, Phd (1)